Travere Therapeutics
TVTX
81 hedge funds and large institutions have $735M invested in Travere Therapeutics in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 7 closing their positions.
358% more call options, than puts
Call options by funds: $53.3M | Put options by funds: $11.6M
229% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 7
179% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 14
177% more capital invested
Capital invested by funds: $265M → $735M (+$470M)
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
25% more funds holding
Funds holding: 65 → 81 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$18.5M |
| 2 |
Millennium Management
New York
|
+$14.3M |
| 3 |
PA
Perceptive Advisors
New York
|
+$12.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.4M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
-$14.6M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$6.4M |
| 3 |
RTS
Round Table Services
Westfield,
New Jersey
|
-$3.29M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$2.39M |
| 5 |
VAM
Visium Asset Management
New York
|
-$1.81M |
TVTX Hedge Fund Activity: Q1 2015 in Review
81 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2015, worth a combined $735M — up 177% from $265M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new TVTX positions and 7 closed out — a net gain of 16 holders — while 39 added to existing stakes and 14 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $18.5M. The largest seller was QVT Financial, cutting an estimated $14.6M.
- 81 institutional investors held Travere Therapeutics (TVTX) as of Q1 2015, up from 65 in Q4 2014.
- Funds reported $735M of Travere Therapeutics stock for Q1 2015, up 177% quarter-over-quarter.
- 23 funds opened new Travere Therapeutics positions in Q1 2015 and 7 closed out, a net change of +16 holders.
- The largest Travere Therapeutics buyer in Q1 2015 was Franklin Resources, an estimated $18.5M added.
- The largest Travere Therapeutics seller in Q1 2015 was QVT Financial, an estimated $14.6M sold.
Based on aggregated 13F filings for Q1 2015.